Electrophysiological Evidence for the Tonic Activation of 5-HT1A Autoreceptors in the Rat Dorsal Raphe Nucleus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Defic
M100907, a Serotonin 5-HT2A Receptor Antagonist and Putative Antipsychotic, Blocks Dizocilpine-Induced Prepulse Inhibition Deficits in Sprague–Dawley and Wistar Rats Geoffrey B. Varty, Ph.D., Vaishali P. Bakshi, Ph.D., and Mark A. Geyer, Ph.D. a In a recent study using Wistar rats, the serotonergic 5-HT2 1 receptor agonist cirazoline disrupts PPI. As risperidone a receptor antagonists ketanserin and risperidone reduced the and M100907 have affinity at the 1 receptor, a final study disruptive effects of the noncompetitive N-methyl-D- examined whether M100907 would block the effects of aspartate (NMDA) antagonist dizocilpine on prepulse cirazoline on PPI. Risperidone partially, but inhibition (PPI), suggesting that there is an interaction nonsignificantly, reduced the effects of dizocilpine in Wistar between serotonin and glutamate in the modulation of PPI. rats, although this effect was smaller than previously In contrast, studies using the noncompetitive NMDA reported. Consistent with previous studies, risperidone did antagonist phencyclidine (PCP) in Sprague–Dawley rats not alter the effects of dizocilpine in Sprague–Dawley rats. found no effect with 5-HT2 antagonists. To test the hypothesis Most importantly, M100907 pretreatment fully blocked the that strain differences might explain the discrepancy in effect of dizocilpine in both strains; whereas SDZ SER 082 these findings, risperidone was tested for its ability to had no effect. M100907 had no influence on PPI by itself reduce the PPI-disruptive effects of dizocilpine in Wistar and did not reduce the effects of cirazoline on PPI. These and Sprague–Dawley rats. Furthermore, to determine studies confirm the suggestion that serotonin and glutamate which serotonergic receptor subtype may mediate this effect, interact in modulating PPI and indicate that the 5-HT2A the 5-HT2A receptor antagonist M100907 (formerly MDL receptor subtype mediates this interaction. -
Covalent Agonists for Studying G Protein-Coupled Receptor Activation
Covalent agonists for studying G protein-coupled receptor activation Dietmar Weicherta, Andrew C. Kruseb, Aashish Manglikb, Christine Hillera, Cheng Zhangb, Harald Hübnera, Brian K. Kobilkab,1, and Peter Gmeinera,1 aDepartment of Chemistry and Pharmacy, Friedrich Alexander University, 91052 Erlangen, Germany; and bDepartment of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305 Contributed by Brian K. Kobilka, June 6, 2014 (sent for review April 21, 2014) Structural studies on G protein-coupled receptors (GPCRs) provide Disulfide-based cross-linking approaches (17, 18) offer important insights into the architecture and function of these the advantage that the covalent binding of disulfide-containing important drug targets. However, the crystallization of GPCRs in compounds is chemoselective for cysteine and enforced by the active states is particularly challenging, requiring the formation of affinity of the ligand-pharmacophore rather than by the elec- stable and conformationally homogeneous ligand-receptor com- trophilicity of the cross-linking function (19). We refer to the plexes. Native hormones, neurotransmitters, and synthetic ago- described ligands as covalent rather than irreversible agonists nists that bind with low affinity are ineffective at stabilizing an because cleavage may be promoted by reducing agents and the active state for crystallogenesis. To promote structural studies on disulfide transfer process is a reversible chemical reaction the pharmacologically highly relevant class -
The Adrenergic Control of Lower Esophageal Sphincter Function: an EXPERIMENTAL MODEL of DENERVATION SUPERSENSITIVITY
The Adrenergic Control of Lower Esophageal Sphincter Function: AN EXPERIMENTAL MODEL OF DENERVATION SUPERSENSITIVITY Anthony J. DiMarino, Sidney Cohen J Clin Invest. 1973;52(9):2264-2271. https://doi.org/10.1172/JCI107413. To evaluate the adrenergic regulation of lower esophageal sphincter (LES) function, LES pressure, LES relaxation during swallowing, and blood pressure were measured in the anesthetized opossum, Didelphis virginiana, during intravenous administration of alpha and beta adrenergic agonists and antagonists. Studies were done in controls and animals adrenergically denervated with 6-hydroxydopamine. Alpha adrenergic agonists (norepinephrine, phenylephrine) increased LES pressure and blood pressure, whereas a beta adrenergic agonist (isoproterenol) decreased both pressures. Alpha adrenergic antagonism (phentolamine) reduced basal LES pressure by 38.3±3.8% (mean ±SEM) (P < 0.001). Beta adrenergic antagonism (propranolol) had no significant effect on either basal LES pressure or percent of LES relaxation with swallowing. After adrenergic denervation with 6-hydroxydopamine, basal LES pressure was reduced by 22.5±5.3% (P < 0.025) but LES relaxation during swallowing was unaltered. In denervated animals, both LES pressure and blood pressure dose response curves showed characteristics of denervation supersensitivity to alpha but not to beta adrenergic agonists. These studies suggest: (a) a significant portion of basal LES pressure is dependent upon alpha adrenergic stimulation; (b) LES relaxation during swallowing is not an adrenergically mediated response; c( ) the LES pressure response to alpha adrenergic agonists after 6-hydroxydopamine may serve as a model of denervation supersensitivity in the gastrointestinal tract. Find the latest version: https://jci.me/107413/pdf The Adrenergic Control of Lower Esophageal Sphincter Function AN EXPERIMENTAL MODEL OF DENERVATION SUPERSENSITIVITY ANTHoNY J. -
Pharmacological Approach to Sleep Disturbances in Autism Spectrum Disorders with Psychiatric Comorbidities: a Literature Review
medical sciences Review Pharmacological Approach to Sleep Disturbances in Autism Spectrum Disorders with Psychiatric Comorbidities: A Literature Review Sachin Relia 1,* and Vijayabharathi Ekambaram 2,* 1 Department of Psychiatry, University of Tennessee Health Sciences Center, 920, Madison Avenue, Suite 200, Memphis, TN 38105, USA 2 Department of Psychiatry, University of Oklahoma Health Sciences Center, 920, Stanton L Young Blvd, Oklahoma City, OK 73104, USA * Correspondence: [email protected] (S.R.); [email protected] (V.E.); Tel.: +1-901-448-4266 (S.R.); +1-405-271-5251 (V.E.); Fax: +1-901-297-6337 (S.R.); +1-405-271-3808 (V.E.) Received: 15 August 2018; Accepted: 17 October 2018; Published: 25 October 2018 Abstract: Autism is a developmental disability that can cause significant emotional, social and behavioral dysfunction. Sleep disorders co-occur in approximately half of the patients with autism spectrum disorder (ASD). Sleep problems in individuals with ASD have also been associated with poor social interaction, increased stereotypy, problems in communication, and overall autistic behavior. Behavioral interventions are considered a primary modality of treatment. There is limited evidence for psychopharmacological treatments in autism; however, these are frequently prescribed. Melatonin, antipsychotics, antidepressants, and α agonists have generally been used with melatonin, having a relatively large body of evidence. Further research and information are needed to guide and individualize treatment for this population group. Keywords: autism spectrum disorder; sleep disorders in ASD; medications for sleep disorders in ASD; comorbidities in ASD 1. Introduction Autism is a developmental disability that can cause significant emotional, social, and behavioral dysfunction. According to the Diagnostic and Statistical Manual (DSM-V) classification [1], autism spectrum disorder (ASD) is characterized by persistent deficits in domains of social communication, social interaction, restricted and repetitive patterns of behavior, interests, or activities. -
Brain Structure and Function Related to Headache
Review Cephalalgia 0(0) 1–26 ! International Headache Society 2018 Brain structure and function related Reprints and permissions: sagepub.co.uk/journalsPermissions.nav to headache: Brainstem structure and DOI: 10.1177/0333102418784698 function in headache journals.sagepub.com/home/cep Marta Vila-Pueyo1 , Jan Hoffmann2 , Marcela Romero-Reyes3 and Simon Akerman3 Abstract Objective: To review and discuss the literature relevant to the role of brainstem structure and function in headache. Background: Primary headache disorders, such as migraine and cluster headache, are considered disorders of the brain. As well as head-related pain, these headache disorders are also associated with other neurological symptoms, such as those related to sensory, homeostatic, autonomic, cognitive and affective processing that can all occur before, during or even after headache has ceased. Many imaging studies demonstrate activation in brainstem areas that appear specifically associated with headache disorders, especially migraine, which may be related to the mechanisms of many of these symptoms. This is further supported by preclinical studies, which demonstrate that modulation of specific brainstem nuclei alters sensory processing relevant to these symptoms, including headache, cranial autonomic responses and homeostatic mechanisms. Review focus: This review will specifically focus on the role of brainstem structures relevant to primary headaches, including medullary, pontine, and midbrain, and describe their functional role and how they relate to mechanisms -
Analysis of Pacemaker Activity in a Two-Component Model of Some
Analysis of pacemaker activity in a two-component model of some brainstem neurons Henry C. Tuckwell1,2∗, Ying Zhou3,, Nicholas J. Penington 4,5 1 School of Electrical and Electronic Engineering, University of Adelaide, Adelaide, South Australia 5005, Australia 2 School of Mathematical Sciences, Monash University, Clayton, Victoria 3800, Australia 3 Department of Mathematics, Lafayette College, 1 Pardee Drive, Easton, PA 18042, USA 4 Department of Physiology and Pharmacology, 5 Program in Neural and Behavioral Science and Robert F. Furchgott Center for Neural and Behavioral Science State University of New York, Downstate Medical Center, Box 29, 450 Clarkson Avenue, Brooklyn, NY 11203-2098, USA ∗ Corresponding author: Henry C. Tuckwell, School of Electrical and Electronic Engineering, University of Adelaide, North Terrace, Adelaide, SA 5005, Australia; Tel: 61-481192816; Fax: 61-8-83134360: email: [email protected] September 11, 2018 arXiv:1704.03941v2 [q-bio.NC] 15 Apr 2017 1 Abstract Serotonergic, noradrenergic and dopaminergic brainstem (including midbrain) neu- rons, often exhibit spontaneous and fairly regular spiking with frequencies of order a few Hz, though dopaminergic and noradrenergic neurons only exhibit such pacemaker- type activity in vitro or in vivo under special conditions. A large number of ion channel types contribute to such spiking so that detailed modeling of spike generation leads to the requirement of solving very large systems of differential equations. It is use- ful to have simplified mathematical models of spiking in such neurons so that, for example, features of inputs and output spike trains can be incorporated including stochastic effects for possible use in network models. -
Inputs to Serotonergic Neurons Revealed by Conditional Viral Transneuronal Tracing
The Journal of Comparative Neurology 514:145–160 (2009) Research in Systems Neuroscience Inputs to Serotonergic Neurons Revealed by Conditional Viral Transneuronal Tracing 1 2 1 JOA˜ O M. BRAZ, * LYNN W. ENQUIST, AND ALLAN I. BASBAUM 1Departments of Anatomy and Physiology and W.M. Keck Foundation Center for Integrative Neuroscience, University of California San Francisco, San Francisco, California 94158 2Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544 ABSTRACT the dorsal raphe (DR) and the nucleus raphe magnus of the Descending projections arising from brainstem serotoner- rostroventral medulla (RVM). Among these are several cat- gic (5HT) neurons contribute to both facilitatory and inhibi- echolaminergic and cholinergic cell groups, the periaque- tory controls of spinal cord “pain” transmission neurons. ductal gray, several brainstem reticular nuclei, and the nu- Unclear, however, are the brainstem networks that influ- cleus of the solitary tract. We conclude that a brainstem 5HT ence the output of these 5HT neurons. To address this network integrates somatic and visceral inputs arising from question, here we used a novel neuroanatomical tracing various areas of the body. We also identified a circuit that method in a transgenic line of mice in which Cre recombi- arises from projection neurons of deep spinal cord laminae nase is selectively expressed in 5HT neurons (ePet-Cre V–VIII and targets the 5HT neurons of the NRM, but not of mice). Specifically, we injected the conditional pseudora- the DR. This spinoreticular pathway constitutes an anatom- bies virus recombinant (BA2001) that can replicate only in ical substrate through which a noxious stimulus can acti- Cre-expressing neurons. -
α2-Adrenoceptor and 5-Ht3 Serotonin Receptor
Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2012 α2-ADRENOCEPTOR AND 5-HT3 SEROTONIN RECEPTOR LIGANDS AS POTENTIAL ANALGESIC ADJUVANTS Genevieve Alley Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Pharmacy and Pharmaceutical Sciences Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2867 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. © Genevieve Sirles Alley 2012 All Rights Reserved i α2-ADRENOCEPTOR AND 5-HT3 SEROTONIN RECEPTOR LIGANDS AS POTENTIAL ANALGESIC ADJUVANTS A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. by Genevieve Sirles Alley Bachelor of Science in Biology, Virginia Commonwealth University 2005 Director: Małgorzata Dukat, Ph.D. Associate Professor, Department of Medicinal Chemistry Virginia Commonwealth University Richmond, Virginia August 2012 ii ACKNOWLEDGMENT First, I would like to thank Dr. Małgorzata Dukat for her continued assistance and advice throughout my studies. This guidance has helped me better understand and appreciate medicinal chemistry. Also, a special thanks is given to both Dr. Dukat and Dr. Richard A. Glennon for their constant quizzing during group meetings, which not only helped me recongnize what I did not already understand, but also, improved my ability to devise potential solutions for future research problems. Furthermore, I could not have successfully completed this dissertation work without the help of Dr. -
Drug Interactions with Tobacco Smoke: Implications for Patient Care
Savvy Psychopharmacology Drug interactions with tobacco smoke: Implications for patient care Martha P. Fankhauser, MS Pharm, FASHP, BCPP rs. C, age 51, experiences exacerbated setron, and zolpidem). When Mrs. C stops asthma and difficulty breathing and smoking while in the hospital, she could M is admitted to a non-smoking hospi- experience higher serum concentrations and tal. She also has chronic obstructive pulmonary adverse effects of these medications. If Mrs. disease, type 2 diabetes mellitus, hyperten- C resumes smoking after bring discharged, sion, hypercholesterolemia, hypothyroidism, metabolism and clearance of any medica- gastroesophageal reflux disease, overactive tions started while she was hospitalized that Vicki L. Ellingrod, bladder, muscle spasms, fibromyalgia, bipolar are substrates of CYP1A2 enzymes could be PharmD, BCPP, FCCP disorder, insomnia, and nicotine and caffeine increased, which could lead to reduced effi- Series Editor dependence. She takes 19 prescribed and over- cacy and poor clinical outcomes. the-counter medications, drinks up to 8 cups of coffee per day, and smokes 20 to 30 cigarettes Pharmacokinetic effects per day. In the emergency room, she receives Polycyclic aromatic hydrocarbons in to- albuterol/ipratropium inhalation therapy to help bacco smoke induce hepatic CYP1A1, 1A2, her breathing and a 21-mg nicotine replacement and possibly 2E1 isoenzymes.6-12 CYP1A2 patch to avoid nicotine withdrawal. is a hepatic enzyme responsible for me- In the United States, 19% of adults smoke Practice Points cigarettes.1 Heavy tobacco smoking and • Tobacco smokers often are treated with nicotine dependence are common among medications that are metabolized by psychiatric patients and contribute to high- hepatic cytochrome (CYP) 1A2 enzymes. -
Alpha 2 Adrenergic Agonists Stimulate Na+-H+ Antiport Activity in the Rabbit Renal Proximal Tubule
Alpha 2 adrenergic agonists stimulate Na+-H+ antiport activity in the rabbit renal proximal tubule. E P Nord, … , S Vaystub, P A Insel J Clin Invest. 1987;80(6):1755-1762. https://doi.org/10.1172/JCI113268. Research Article The role of adrenergic agents in augmenting proximal tubular salt and water flux, was studied in a preparation of freshly isolated rabbit renal proximal tubular cells in suspension. Norepinephrine (NE, 10(-5) M) increased sodium influx (JNa) 60 +/- 5% above control value. The alpha adrenergic antagonist, phentolamine (10(-5) M), inhibited the NE-induced enhanced JNa by 90 +/- 2%, while the beta adrenergic antagonist, propranolol, had a minimal inhibitory effect (10 +/- 2%). The alpha adrenergic subtype was further defined. Yohimbine (10(-5) M), an alpha2 adrenergic antagonist but not prazosin (10(-5) M), an alpha1 adrenergic antagonist completely blocked the NE induced increase in JNa. Clonidine, a partial alpha2 adrenergic agonist, increased JNa by 58 +/- 2% comparable to that observed with NE (10(-5) M). Yohimbine, but not prazosin, inhibited the clonidine-induced increase in JNa, confirming that alpha2 adrenergic receptors were involved. Additional alpha2 adrenergic agents, notably p-amino clonidine and alpha-methyl-norepinephrine, imparted a similar increase in JNa. The clonidine-induced increase in JNa could be completely blocked by the amiloride analogue, ethylisopropyl amiloride (EIPA, 10(-5) M). The transport pathway blocked by EIPA was partially inhibited by Li and cis H+, but stimulated by trans H+, consistent with Na+-H+ antiport. Radioligand binding studies using [3H]prazosin (alpha1 adrenergic antagonist) and [3H]rauwolscine (alpha2 adrenergic antagonist) were performed to complement the flux studies. -
Impact of Depressogenic- and Antidepressant-Like
Impact of depressogenic- and antidepressant-like challenges on monoamine system activities: in vivo electrophysiological characterization studies Chris A. Oosterhof Department of Cellular & Molecular Medicine University of Ottawa Thesis submitted in partial fulfillment of the requirements for the Doctor of Philosophy Degree in Neuroscience © Chris A. Oosterhof, Ottawa, Canada, 2016 Table of contents Table of contents ............................................................................................................. ii Acknowledgements ........................................................................................................ iv Statement of contributions .............................................................................................. v List of figures ................................................................................................................. vi List of tables .................................................................................................................. vii Glossary ........................................................................................................................ viii Abstract .......................................................................................................................... xi 1) Major depressive disorder ............................................................................................... 1 2) Monoamine systems....................................................................................................... -
Involvement of Lateral Habenula-Dorsal Raphe Neurons in the Differential Regulation of Striatal and Nigral Serotonergic Transmission in Cats’
0270~6474/82/0208-1062$02.00/O The Journal of Neuroscience Copyright 0 Society for Neuroscience Vol. 2, No. 8, pp. 1062-1071 Printed in U.S.A. August 1982 INVOLVEMENT OF LATERAL HABENULA-DORSAL RAPHE NEURONS IN THE DIFFERENTIAL REGULATION OF STRIATAL AND NIGRAL SEROTONERGIC TRANSMISSION IN CATS’ TERRY D. REISINE,’ PHILIPPE SOUBRIE, FRANCOISE ARTAUD, AND JACQUES GLOWINSK13 Groupe NB, Institut National de la Sante’ et de la Recherche Mkdicale (INSERM, U. 114), College de France, 75231 Paris Cedex 5, France Received December 15, 1981; Revised March 5, 1982; Accepted March 8, 1982 Abstract The importance of the lateral habenula-dorsal raphe pathway in the control of in uiuo [3H] serotonin release in the cat basal ganglia was examined using the push-pull cannula technique and an isotopic method for the estimation of [3H]serotonin continuously formed from [3H]tryptophan. [“H]Serotonin was measured in both caudate nuclei and substantiae nigra and, in some cases, in the dorsal raphe. Electrical stimulation of the lateral habenula decreased [3H]serotonin release in all structures studied. Blockade of the GABA inhibitory pathway to the lateral habenula by the local application of picrotoxin reduced [3H]serotonin release in both substantiae nigra and increased release of the 3H-amine in the dorsal raphe but was without effect on [3H]serotonin release in either caudate nucleus. This inhibition of nigral [3H]serotonin release was antagonized by simultaneous application of picrotoxin to the dorsal raphe. Substance P delivery to the dorsal raphe produced the same effects on [3H]serotonin release as described for picrotoxin application to the lateral habenula except that inhibition of nigral [3H]serotonin release was not prevented by local co-administration of picrotoxin.